Vor Biopharma (VOR) Treasury Shares (2020 - 2026)

Vor Biopharma (VOR) posted quarterly Treasury Shares of $346325.0 for Q1 2026, up 85.87% quarter-over-quarter from $186325.0 in Q4 2025.

Vor Biopharma (VOR) Treasury Shares (2020 - 2026) Analysis & Trends

Vor Biopharma (VOR) has reported Treasury Shares for 6 consecutive years, with $346325.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Treasury Shares changed N/A year-over-year to $346325.0; the TTM figure through Mar 2026 stood at $346325.0 (changed N/A YoY), while the FY2025 annual figure was $186325.0, up 182.11% from the prior year.
Treasury Shares grew to $346325.0 in Q1 2026 per VOR's latest filing, from $186325.0 in the prior quarter.
Across five years, Treasury Shares topped out at $1.4 million in Q4 2022 and bottomed at $66046.0 in Q4 2024.
Historically, Treasury Shares has averaged $628455.4 across 5 years, with a median of $346325.0 in 2026.
Annual changes were most pronounced in 2024 — Treasury Shares tumbled 94.07% — and 2025, when it soared 182.11%.
Vor Biopharma's Treasury Shares stood at $1.4 million in 2022, then retreated by 22.15% to $1.1 million in 2023, then sank by 94.07% to $66046.0 in 2024, then jumped by 182.11% to $186325.0 in 2025, then surged by 85.87% to $346325.0 in 2026.
Business Quant data shows VOR's Treasury Shares at $346325.0 in Q1 2026, $186325.0 in Q4 2025, and $66046.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Vor Biopharma	1.36 Bn	1.36 Bn	-	373,811.00

Download Data